![logo](/logos/AXGN.webp)
AxoGen, Inc.
NASDAQ:AXGN
13.02 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | AxoGen, Inc. |
Symbool | AXGN |
Munteenheid | USD |
Prijs | 13.02 |
Beurswaarde | 570,663,996 |
Dividendpercentage | 0% |
52-weken bereik | 3.45 - 13.348 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Ms. Karen Zaderej |
Website | https://www.axogeninc.com |
An error occurred while fetching data.
Over AxoGen, Inc.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)